Insider · CIK 0001752631

Manning Meredith

Reports to the SEC for 3 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001752631

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-18	SOLENO THERAPEUTICS INCD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−64.5K sh	—	—	0
2026-05-18	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−91K sh	—	—	0
2026-05-18	SOLENO THERAPEUTICS INCEmployee Stock Option (Right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−29.2K sh	—	—	0
2026-05-18	SOLENO THERAPEUTICS INCEmployee Stock Option (Right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−32.8K sh	—	—	0
2026-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−4,864 sh	$30.04	−$146K	67,165
2026-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−2,100 sh	$31.04	−$65.2K	65,065
2026-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−558 sh	$31.72	−$17.7K	64,507
2026-01-21	SOLENO THERAPEUTICS INCA Award	Chief Commercial Officer	AAward	+28.6K sh	—	—	72,029
2026-01-21	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)A Award	Chief Commercial Officer	AAward	+32.8K sh	—	—	32,800
2025-12-15	SOLENO THERAPEUTICS INCF Tax Payment	Chief Commercial Officer	FTax Payment	−1,922 sh	$49.95	−$96K	43,429
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−668 sh	$65.97	−$44.1K	52,932
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−1,087 sh	$66.79	−$72.6K	51,845
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−1,976 sh	$67.70	−$134K	49,869
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−2,599 sh	$68.79	−$179K	47,270
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−1,505 sh	$69.84	−$105K	45,765
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−155 sh	$70.73	−$11K	45,610
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−225 sh	$71.74	−$16.1K	45,385
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−34 sh	$72.64	−$2,469.729	45,351
2025-03-27	SOLENO THERAPEUTICS INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+37K sh	$46.31	+$1.71M	82,351
2025-03-27	SOLENO THERAPEUTICS INCS Sale	Chief Commercial Officer	SSale	−37K sh	$67.04	−$2.48M	45,351
2025-03-27	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−37K sh	—	—	91,000
2025-01-21	SOLENO THERAPEUTICS INCA Award	Chief Commercial Officer	AAward	+13.6K sh	—	—	53,600
2025-01-21	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)A Award	Chief Commercial Officer	AAward	+29.2K sh	—	—	29,200
2024-07-17	SOLENO THERAPEUTICS INCA Award	Chief Commercial Officer	AAward	+40K sh	—	—	40,000
2019-02-27	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+26K sh	—	—	26,000
2018-09-17	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+175K sh	—	—	175,000

Recent filings

Accepted (ET)
May 184
Manning Meredith0001752631-26-000003
SEC(opens sec.gov)
Mar 314
Manning Meredith0001752631-26-000002
SEC(opens sec.gov)
Jan 234
Manning Meredith0001752631-26-000001
SEC(opens sec.gov)
Dec 174
Manning Meredith0001752631-25-000004
SEC(opens sec.gov)
Mar 314
Manning Meredith0001415889-25-009296
SEC(opens sec.gov)

Companies

Address

C/O UNICYCIVE THERAPEUTICS, INC. 1975 W. EL CAMINO REAL, SUITE 204

MOUNTAIN VIEW, CA, 94040